HAS Healthcare Advanced Synthesis SA showcases in the upcoming 2024 CPhI North America trade show in Philadelphia.
HAS Healthcare Advanced Synthesis SA (“HAS”), a full-service contract development and manufacturing organization (CDMO) delivering high-quality, exclusive, personalized solutions to its healthcare clients, today announces its participation as exhibitor in the 2024 CPhI North America trade show that will be hosted at Pennsylvania Convention Center in Philadelphia, on 7 – 9 May 2024.
CPhI North America serves as an exceptional entry point to the United States pharmaceutical market. It facilitates networking with suppliers, innovators, and industry leaders, fostering collaborations within the global pharma community.
At our booth, #1446, we will highlight our state-of-the-art contract manufacturing facilities located in southern Switzerland. These facilities offer tailored, advanced, and top-quality solutions for pharmaceutical and biotech companies.
HAS, with unwavering passion, tailors its services to meet the clinical and commercial manufacturing needs of our clients. We go the extra mile to support them in their analytical and regulatory requirements. Our commitment to sustainability and ethical practices drives us to create positive impacts within our community and on our planet.
Our specialization lies in delivering oncology and rare disease compounds, and our impressive track record includes reducing time-to-market for life-saving products in these critical areas. As a result, we remain at the forefront of the global pharmaceutical industry.
Join us at our booth and be part of the future of pharma, where innovation and life-changing breakthroughs await.
If you cannot make it to Philadelphia , connect to our website and learn more on how we offer the best CDMO standards as a full-service partner to our healthcare clients: www.hashealthcare.com and follow us on LinkedIn
About HAS
HAS Healthcare Advanced Synthesis is a CDMO that offers a full range of customized services from laboratory development to manufacturing. HAS Healthcare Advanced Synthesis develops and produces active pharmaceutical ingredients (APIs), advanced intermediates, high-activity active pharmaceutical ingredients (HPAPIs) and anticancer compounds.
The production facility is located in Biasca, Switzerland, and was founded in 1984. The site is regularly inspected by SwissMedic, the FDA and other global regulatory agencies. The production scale ranges from a few hundred grams to tens of kilograms for highly active ingredients (HPAPI) and anticancer and from kilograms to tens of tons for standard active ingredients (APIs); the plants are completely dedicated to cGMP production.
Contact Press Office
HAS Healthcare Advanced Synthesis
Biasca, Switzerland
Giacomo Braglia
Tel: +41 (0) 91 873 94 00
Email: [email protected]